Healthpeak Properties (NYSE:DOC) Updates FY 2024 Earnings Guidance

Healthpeak Properties (NYSE:DOCGet Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.560-1.580 for the period, compared to the consensus earnings per share estimate of 1.790. The company issued revenue guidance of -. Healthpeak Properties also updated its FY24 guidance to $1.79-1.81 EPS.

Analyst Upgrades and Downgrades

DOC has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price objective for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Evercore ISI boosted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. Wells Fargo & Company restated an “equal weight” rating and set a $23.00 price target (up from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Royal Bank of Canada upped their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 30th. Finally, StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Saturday, October 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.62.

Check Out Our Latest Report on DOC

Healthpeak Properties Stock Performance

Shares of DOC stock traded down $0.71 on Friday, reaching $22.29. The stock had a trading volume of 8,802,307 shares, compared to its average volume of 4,002,954. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. Healthpeak Properties has a 1 year low of $15.24 and a 1 year high of $23.26. The stock has a market cap of $15.59 billion, a P/E ratio of 47.43, a price-to-earnings-growth ratio of 3.30 and a beta of 1.14. The company has a 50 day simple moving average of $22.26 and a 200 day simple moving average of $20.67.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.23). The firm had revenue of $695.50 million during the quarter, compared to analysts’ expectations of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The company’s revenue for the quarter was up 27.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.45 earnings per share. Equities research analysts expect that Healthpeak Properties will post 1.79 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.38%. The ex-dividend date is Monday, November 4th. Healthpeak Properties’s payout ratio is 255.32%.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Stories

Earnings History and Estimates for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.